![Quiver Logo](/static/img/logo-icon.png)
![CYTO logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cyto.png)
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CYTO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CYTO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CYTO's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CYTO
Recent picks made for CYTO stock on CNBC
ETFs with the largest estimated holdings in CYTO
Flights by private jets registered to CYTO
![Quiver Logo](/static/img/logo-icon.png)